Jun Chen

31.4k total citations · 2 hit papers
799 papers, 15.7k citations indexed

About

Jun Chen is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Jun Chen has authored 799 papers receiving a total of 15.7k indexed citations (citations by other indexed papers that have themselves been cited), including 271 papers in Molecular Biology, 260 papers in Pulmonary and Respiratory Medicine and 224 papers in Oncology. Recurrent topics in Jun Chen's work include Lung Cancer Treatments and Mutations (93 papers), Cancer-related molecular mechanisms research (86 papers) and RNA modifications and cancer (66 papers). Jun Chen is often cited by papers focused on Lung Cancer Treatments and Mutations (93 papers), Cancer-related molecular mechanisms research (86 papers) and RNA modifications and cancer (66 papers). Jun Chen collaborates with scholars based in China, United States and Taiwan. Jun Chen's co-authors include Lori A. Setton, Hongyu Liu, Qinghua Zhou, Yan Xu, André Veillette, Roger P. Simon, Hongyu Liu, Liufang Jing, Li Y and Ming Hu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Jun Chen

747 papers receiving 15.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comparisons between the National Comprehensive Cancer Network (NCCN) non-small-cell lung cancer (NSCLC) Clinical Practice Guidelines (Chinese version), the NCCN original edition, and the European Society for Medical Oncology NSCLC Guidelines in 2009

2010 743 citations Jun Chen, Qinghua Zhou et al. Thoracic Cancer profile →
SIRPα–CD47 Immune Checkpoint Blockade in Anticancer Therapy

2018 360 citations André Veillette, Jun Chen profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jun Chen China	61	6.6k	3.8k	3.8k	3.4k	2.1k	799	15.7k
Lei Zhang China	66	8.5k 1.3×	5.2k 1.4×	2.5k 0.7×	3.0k 0.9×	1.5k 0.7×	658	16.5k
Michele Caraglia Italy	65	7.4k 1.1×	3.2k 0.9×	5.0k 1.3×	2.1k 0.6×	1.0k 0.5×	488	16.0k
Athanasios G. Papavassiliou Greece	68	8.0k 1.2×	2.7k 0.7×	3.2k 0.8×	1.3k 0.4×	1.4k 0.7×	488	17.5k
Hong Wang United States	80	9.9k 1.5×	3.1k 0.8×	6.9k 1.8×	3.4k 1.0×	2.0k 0.9×	749	25.2k
Masabumi Shibuya Japan	68	12.6k 1.9×	3.8k 1.0×	4.8k 1.3×	1.6k 0.5×	1.9k 0.9×	215	20.7k
Yi Li China	65	9.7k 1.5×	3.2k 0.8×	5.4k 1.4×	1.6k 0.5×	1.2k 0.5×	695	19.1k
Qi Zhang China	66	7.7k 1.2×	4.4k 1.2×	3.8k 1.0×	1.3k 0.4×	876 0.4×	663	16.7k
Michiaki Kubo Japan	77	5.1k 0.8×	2.0k 0.5×	2.0k 0.5×	2.0k 0.6×	1.5k 0.7×	385	18.3k
Diether Lambrechts Belgium	53	6.3k 1.0×	2.8k 0.7×	3.9k 1.0×	2.1k 0.6×	1.5k 0.7×	296	14.4k
Jian Wang China	59	6.2k 0.9×	3.4k 0.9×	3.2k 0.8×	1.7k 0.5×	932 0.4×	598	13.2k

Countries citing papers authored by Jun Chen

Since Specialization

Citations

This map shows the geographic impact of Jun Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Chen more than expected).

Fields of papers citing papers by Jun Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Chen. The network helps show where Jun Chen may publish in the future.

Co-authorship network of co-authors of Jun Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Jun Chen. A scholar is included among the top collaborators of Jun Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun Chen. Jun Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yang, Dongli, et al.. (2025). Generation, characterization, and validation of two human induced pluripotent stem cell lines from the peripheral blood of young and older adults. Stem Cell Research. 83. 103670–103670.

Yuan, Ping, Jun Chen, Shang Wang, et al.. (2024). Impact of different sequential triple oral combination therapies based selexipag on outcomes in pulmonary arterial hypertension. Clinical Cardiology. 47(2). 1 indexed citations

Huang, Yaqing, et al.. (2024). Diagnostic value of high-resolution ultrasound combined with multi-slice computer tomography (MSCT) for pediatric intra-abdominal hernias: a retrospective study. BMC Surgery. 24(1). 190–190.

Chen, Ying, et al.. (2024). Long-term risks of cardiovascular-specific mortality among myeloproliferative neoplasms patients. Therapeutic Advances in Hematology. 15. 1574208646–1574208646. 1 indexed citations

Wang, Zhouyu, Wei Le, Lei Yan, et al.. (2023). Case Report: Response to crizotinib treatment in a patient with advanced non-small cell lung cancer with LDLR-ROS1 fusion. Frontiers in Oncology. 13. 1169876–1169876. 1 indexed citations

Chen, Jun, et al.. (2023). MiR-204-5p regulates HUVEC cell inflammation and apoptosis by targeting P4HB. Cellular and Molecular Biology. 69(9). 207–212. 1 indexed citations

He, Jin, Fan Wu, Junfeng Li, et al.. (2023). Tumor suppressor CLCA1 inhibits angiogenesis via TGFB1/SMAD/VEGF cascade and sensitizes hepatocellular carcinoma cells to Sorafenib. Digestive and Liver Disease. 56(1). 176–186. 4 indexed citations

Zhu, Guangsheng, Hua Huang, Ruifeng Shi, et al.. (2021). Prognostic value of ferroptosis‐related genes in patients with lung adenocarcinoma. Thoracic Cancer. 12(12). 1890–1899. 15 indexed citations

Liu, Tingting, et al.. (2021). Comparative efficacy of treatments for previously treated patients with advanced esophageal and esophagogastric junction cancer: A network meta-analysis. PLoS ONE. 16(6). e0252751–e0252751. 4 indexed citations

10.

Shi, Feng, Bo Wei, Tian Lan, et al.. (2021). Low NLRP3 expression predicts a better prognosis of colorectal cancer. Bioscience Reports. 41(4). 48 indexed citations

11.

Feng, Qing, et al.. (2020). Laparoscopic versus open gastrectomy for Siewert type II/III adenocarcinoma of the esophagogastric junction: a meta-analysis. Surgical Endoscopy. 35(2). 860–871. 4 indexed citations

12.

Li, Hui, et al.. (2019). Expression and significance of Nrf2 and caspase-3 in non-small cell lung cancer. 21(5). 688–691. 1 indexed citations

13.

Guo, Huaijian, Stacey Cranert, Yan Lü, et al.. (2016). Deletion of Slam locus in mice reveals inhibitory role of SLAM family in NK cell responses regulated by cytokines and LFA-1. The Journal of Experimental Medicine. 213(10). 2187–2207. 22 indexed citations

14.

He, Jian, Hua Shi, Jun Chen, et al.. (2015). Correlation between apparent diffusion coefficients and HER2 status in gastric cancers: pilot study. BMC Cancer. 15(1). 749–749. 22 indexed citations

15.

Chen, Jun, Hengjun Xiao, Zhiming Hu, et al.. (2014). AB97. MicroRNA124 regulate cell growth of prostate cancer cells by targeting iASPP.. Translational Andrology and Urology. 3. 250–250.

16.

Chen, Jun, Xiao‐Ming Xu, Zao C. Xu, & John H. Zhang. (2012). Animal Models of Acute Neurological Injuries II. 1 indexed citations

17.

Nadiminty, Nagalakshmi, Wei Lou, Meng Sun, et al.. (2010). Aberrant Activation of the Androgen Receptor by NF-κB2/p52 in Prostate Cancer Cells. Cancer Research. 70(8). 3309–3319. 91 indexed citations

18.

Zhang, Xiaoyan, Jun Chen, Yufang Zheng, et al.. (2009). Follicle-Stimulating Hormone Peptide Can Facilitate Paclitaxel Nanoparticles to Target Ovarian Carcinoma In vivo. Cancer Research. 69(16). 6506–6514. 80 indexed citations

19.

Chen, Jun, Susann Patschan, & Michael S. Goligorsky. (2008). Stress-induced premature senescence of endothelial cells. Journal of Nephrology. 21(3). 337–344. 22 indexed citations

20.

Malumbres, Raquel, Jun Chen, Rob Tibshirani, et al.. (2008). Paraffin-based 6-gene model predicts outcome in diffuse large B-cell lymphoma patients treated with R-CHOP. Blood. 111(12). 5509–5514. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact